Upfront Payments and License Fees Received

No definition available.

Name:	glpg_UpfrontPaymentsAndLicenseFeesReceived
Namespace Prefix:	glpg_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of current financial liabilities. [Refer: Financial liabilities]

+ References

+ Details

Name:	ifrs-full_CurrentFinancialLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The decrease in financial assets resulting from derecognition. [Refer: Financial assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph IG20B
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance
-URIDate 2019-03-27

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph 35I
-Subparagraph c
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_35I_c&doctype=Standard
-URIDate 2019-03-27

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph 35H
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_35H&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_DecreaseThroughDerecognitionFinancialAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph 25
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_25&doctype=Standard
-URIDate 2019-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph 35H
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_35H&doctype=Standard
-URIDate 2019-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph 35I
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_35I&doctype=Standard
-URIDate 2019-03-27

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph 35M
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_35M&doctype=Standard
-URIDate 2019-03-27

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 7
-IssueDate 2019-01-01
-Paragraph 35N
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2019-en-r&anchor=para_35N&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_FinancialAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity’s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity’s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]

+ References

+ Details

Name:	ifrs-full_FinancialLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The gains (losses) recognised in profit or loss for the entity's own equity instruments measured at fair value that are attributable to the change in unrealised gains or losses relating to those instruments held at the end of the reporting period. [Refer: At fair value [member]; Entity's own equity instruments [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2019-01-01
-Paragraph 93
-Subparagraph f
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2019-en-r&anchor=para_93_f&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForEntitysOwnEquityInstrumentsHeldAtEndOfPeriodFairValueMeasurement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase in equity through the issue of equity instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2019-01-01
-Paragraph 106
-Subparagraph d
-Clause iii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_106_d_iii&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_IssueOfEquity
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	ifrs-full_HedgingInstrumentsAxis=ifrs-full_DerivativesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CounterpartiesAxis=glpg_GileadSciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_HedgingInstrumentsAxis=glpg_FairValueReMeasurementOfShareSubscriptionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_HedgingInstrumentsAxis=glpg_FairValueReMeasurementOfFinancialInstrumentRelatedToIssuanceOfWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ClassesOfShareCapitalAxis=glpg_WarrantaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_HedgingInstrumentsAxis=glpg_FairValueReMeasurementOfFinancialInstrumentRelatedToIssuanceOfInitialWarrantBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ClassesOfShareCapitalAxis=glpg_WarrantBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Fair value re-measurement of share subscription agreement and warrants granted to Gilead - Financial assets (Details) - EUR (€) € in Thousands				2 Months Ended		12 Months Ended
	Nov. 06, 2019	Nov. 06, 2019	Aug. 23, 2019	Dec. 31, 2019	Aug. 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jul. 14, 2019
Disclosure of fair value measurement of assets [line items]
Upfront payments							€ 38,874	€ 6,000
Share subscription increase						€ 960,087	296,188	363,924
Fair value of financial asset at inception related to the share subscription agreement with Gilead				€ 5,847,242		5,847,242	1,316,539	1,181,545
Fair value of financial liability related to the share subscription agreement with Gilead						(69,540)	(48,727)
Change in fair value related to the share subscription agreement and warrants with/granted to Gilead						(181,644)
Fair value of financial liability				(181,006)		(181,006)	€ (69,540)	€ (48,727)
Current financial liabilities related to the share subscription agreement				6,198		6,198
Derivative financial instrument \| Gilead \| Level 3
Disclosure of fair value measurement of assets [line items]
Fair value of financial asset at inception related to the share subscription agreement with Gilead				0		0			€ 85,601
Change in fair value related to the share subscription agreement and warrants with/granted to Gilead					€ (142,350)
Fair value of financial liability			€ (56,749)
Derecognition of the financial asset through the share premium account related to the share subscription agreement with Gilead			€ 56,749
Fair value re-measurement of the share subscription agreement
Disclosure of fair value measurement of assets [line items]
Change in fair value related to the share subscription agreement and warrants with/granted to Gilead						(142,350)
Fair value re-measurement of the financial instrument related to the issuance of warrant A
Disclosure of fair value measurement of assets [line items]
Change in fair value related to the share subscription agreement and warrants with/granted to Gilead						(35,642)
Fair value re-measurement of the financial instrument related to the issuance of warrant A \| Gilead \| Warrant A
Disclosure of fair value measurement of assets [line items]
Fair value of financial liability related to the share subscription agreement with Gilead		€ (43,311)		(43,311)
Change in fair value related to the share subscription agreement and warrants with/granted to Gilead		(35,642)
Fair value of financial liability				0		0
Derecognition of the financial asset through the share premium account related to the share subscription agreement with Gilead	€ 78,953
Fair value re-measurement of the financial instrument related to the issuance of initial warrant B
Disclosure of fair value measurement of assets [line items]
Change in fair value related to the share subscription agreement and warrants with/granted to Gilead						(3,653)
Fair value re-measurement of the financial instrument related to the issuance of initial warrant B \| Gilead \| Warrant B
Disclosure of fair value measurement of assets [line items]
Fair value of financial liability related to the share subscription agreement with Gilead		€ (2,545)		(2,545)
Change in fair value related to the share subscription agreement and warrants with/granted to Gilead				(3,653)
Fair value of financial liability				€ (6,198)		€ (6,198)